North America and Europe preclinical medical device testing services market size was valued at USD 2.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028. The preclinical medical device testing services market is expected to grow lucratively during the COVID-19 pandemic. The main drivers for this market are the emerging players operating in this industry over the past decade.
The preclinical medical device testing services market is expected to grow lucratively during the COVID-19 pandemic. The main drivers for this market are the emerging player operating in this industry over the past decade. The current COVID-19 pandemic has positively impacted the preclinical medical device testing services market. Growth was slower in the first quarter, but it picked up in the second as the industry learned to operate amid a pandemic.
The major equipment tested is Personal Protective Equipment (PPE), due to the decreased demand for surgical medical devices caused by the COVID-19 pandemic. Advisory services with testing firms are completely booked, as medical device manufacturers rush to be ready for the new EU-MDR, which was supposed to be effective as of May 2021. Other products experiencing an increase in demand are medical testing kits for COVID-19 and ventilators.
The market is competitive, in which they have to fulfill complex requirements for efficacy and safety testing. These requirements vary with the type of medical device. There is a rise in preclinical spending for medical devices, thus contributing to market growth. In 2017 a survey was conducted by the International Federation of Pharmaceutical Manufacturers and Association, and it shows that around USD 149.8 billion was spent on preclinical trials. Modern equipment is composed of complex functions, and the need to test the compliance of the device with regulatory requirements is becoming important. For the device to be accurate, durable, and easy to use, it needs to undergo extensive testing.
The microbiology and sterility testing segment dominated the North America and Europe preclinical medical device testing services market and accounted for the largest revenue share of 34.3% in 2020; it is likely to remain dominant over the forecast period. Producing safe & effective products is a core goal of medical device manufacturers, and sterility assurance is a major component for achieving it. Many single-use medical devices are terminally sterilized by radiation methods, such as e-beam or gamma. In addition, the FDA and other regulatory bodies require validation of the sterilization process, which generally requires sterility testing.
The chemistry test segment is anticipated to exhibit the fastest CAGR of 11.5% over the forecast period. This helps to check the safety parameters of medical devices. These activities are easily outsourced by various companies. For instance, WuXiAppTec performed a chemical evaluation test for a client that failed cytotoxicity testing. Thus, this rise in ancillary testing is expected to boost revenue generation in the industry over the forecasted period.
North America led the market for preclinical medical device testing services, with the largest revenue share of 54.9% in 2020. This is largely due to the presence of a large number of players in this region. It is also the top manufacturing hub for complex, highly reliable, and high-end medical devices. There is a rapid increase in the manufacturing of medical devices to meet the rising demand for efficient and cost-effective healthcare in this region. Besides this, the presence of the FDA is fueling the growth of the market for medical device testing services.
In Europe, the preclinical medical device testing service is expected to witness a CAGR of 10.9% over the forecasted period. This is due to the rising demand for cost-cutting and increasing complexity in product design, which has a high impact on the rendering drivers for the medical device analytical testing outsourcing market in European nations. A steady increase in the outsourcing of services for contract manufacturers and component suppliers has been observed in the last two decades. However, notified bodies such as the European Medical Device Regulation (EMDR) are also involved in the scrutiny of outsourced medical devices.
Key parameters affecting the competitive nature of the market include geographic expansion, collaboration, partnership, mergers, and acquisition. For example, in November 2019, WuXiAppTec lab testing division expanded its toxicology facility in Suzhou China to provide full-service preclinical and clinical-stage toxicology. Some of the prominent players in the North America And Europe preclinical medical device testing services market include:
Nelson Labs
TUV SUD AG
American Preclinical Services
Sterigenics International LLC
Report Attribute |
Details |
Market Size value in 2021 |
USD 2.7 billion |
Revenue forecast in 2028 |
USD 5.6 million |
Growth Rate |
CAGR of 11.2% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD Million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Services, region |
Regional scope |
North America; Europe |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Key companies profiled |
SGS SA, Toxikon, Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc; WUXI APPTEC; TÜV SÜD AG; Sterigenics International LLC; Nelson Labs; North American Science Associates, Inc.; American Preclinical Services; Charles River Laboratories International, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the North America And Europe preclinical medical device testing services market on the basis of services and region:
Services Outlook (Revenue, USD Million, 2016 - 2028)
Biocompatibility Tests
Chemistry Test
Microbiology & Sterility Testing
Bioburden Determination
Pyrogen & Endotoxin Testing
Sterility Test and Validation
Antimicrobial activity testing
Others
Package Validation
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Netherlands
Belgium
Switzerland
Russia
Sweden
b. Some key players operating in the North America and Europe preclinical medical device testing services market include SGS SA, Toxikon, Inc., Eurofins Scientific, Pace Analytical Services LLC, Intertek Group Plc, WUXI APPTEC, TÜV SÜD AG, Sterigenics International LLC, Nelson Labs, North American Science Associates, Inc., American Preclinical Services, Charles River Laboratories International, Inc.
b. Key factors that are driving the North America and Europe preclinical medical device testing services market growth include emerging players operating in this industry over the past decade.
b. North America and Europe preclinical medical device testing services market is expected to register substantial growth owing to the growing stringent regulations for medical devices that are expected to help in the formation of precise and innovative devices.
b. The North America and Europe preclinical medical device testing services market is expected to grow at a compound annual growth rate of 11.2% from 2021 to 2028 to reach USD 5.6 billion by 2028.
b. North America led the market for preclinical medical device testing services, with the largest revenue share of 54.9% in 2020. This is largely due to the presence of a large number of players in this region.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.